يعرض 1 - 20 نتائج من 958 نتيجة بحث عن '"delayed type hypersensitivity"', وقت الاستعلام: 1.11s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المصدر: Human Vaccines & Immunotherapeutics. 10(11)

    مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Brain Cancer, Immunization, Brain Disorders, Cancer, Rare Diseases, Orphan Drug, Neurosciences, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, 6.1 Pharmaceuticals, Animals, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Blood-Brain Barrier, Brain Neoplasms, Camptothecin, Cancer Vaccines, Chemoradiotherapy, Dacarbazine, Disease-Free Survival, ErbB Receptors, Glioblastoma, Humans, Immunotherapy, Irinotecan, Mice, Temozolomide, Vaccination, Vaccines, Subunit, brain, EGFRVIII, glioblastoma, therapies, vaccine, EGFRvIII, The epidermal growth factor receptor variant III, GBM, Glioblastoma Multiforme, WHO, World Health Organization, Y, year, SEER, Surveillance, Epidemiology, and End Results Program, VEGF, Vascular endothelial growth factor, CPT-11, irinotecan, Camptosar, OS, overall survival, PFS, progression-free survival, EORTC, European Organization for Research and Treatment of Cancer, NCIC, National Cancer Institute of Canada, CNS, central nervous system, APC, antigen-presenting cell, MHC, major histocompatibility complex, BBB, blood brain barrier, LPS, lipopolysaccharide, D, day, Ab, antibody, TGF-b, transforming growth factor beta, IL-10, Interleukin-10, PGE2, prostaglandin E2, Treg cells, regulatory T cells, TH2 cells, T helper type 2 cells, CD4, cluster of differentiation 4, CD25, cluster of differentiation 25, IL-2, Interleukin-2, GAGE, G antigen gene family, Ras, rat sarcoma genes, Grb2, Growth factor receptor-bound protein 2, KLH, keyhole limpet hemocyanin, CTL, Cytotoxic T lymphocytes, HLA, human leukocyte antigen, DTH, delayed-type hypersensitivity, ACTIVATE, A Complementary Trial of an Immunotherapy Vaccine against Tumor Specific EGRFvIII, TMZ, temozolomide, KPS, Karnofsky performance status, TTP, time to progression, GM-CSF, Granulocyte-macrophage colony-stimulating factor, MGMT, O-6-methylguanine-DNA methyltransferase, INF-g, Interferon gamma, IL-12, Interleukin-12, ACTIVATE, A Complementary Trial of an Immunotherapy Vaccine against Tumor Specific EGRFvIII, APC, antigen-presenting cell, Ab, antibody, BBB, blood brain barrier, CD25, cluster of differentiation 25, CD4, cluster of differentiation 4, CNS, central nervous system, CPT-11, irinotecan, Camptosar, CTL, Cytotoxic T lymphocytes, D, day, DTH, delayed-type hypersensitivity, EGFRvIII, The epidermal growth factor receptor variant III, EORTC, European Organization for Research and Treatment of Cancer, GAGE, G antigen gene family, GBM, Glioblastoma Multiforme, GM-CSF, Granulocyte-macrophage colony-stimulating factor, Grb2, Growth factor receptor-bound protein 2, HLA, human leukocyte antigen, IL-10, Interleukin-10, IL-12, Interleukin-12, IL-2, Interleukin-2, INF-g, Interferon gamma, KLH, keyhole limpet hemocyanin, KPS, Karnofsky performance status, LPS, lipopolysaccharide, MGMT, O-6-methylguanine-DNA methyltransferase, MHC, major histocompatibility complex, NCIC, National Cancer Institute of Canada, OS, overall survival, PFS, progression-free survival, PGE2, prostaglandin E2, Ras, rat sarcoma genes, SEER, Surveillance, Epidemiology, and End Results Program, TGF-b, transforming growth factor beta, TH2 cells, T helper type 2 cells, TMZ, temozolomide, TTP, time to progression, Treg cells, regulatory T cells, VEGF, Vascular endothelial growth factor, WHO, World Health Organization, Y, year, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology, Medical biotechnology, Medical microbiology

    وصف الملف: application/pdf